The ROE as of November 2024 (TTM) for Immix Biopharma, Inc. (IMMX) is -102.10%

According to Immix Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -102.10%. This represents a change of 274.73% compared to the average of -27.25% of the last 4 quarters.

Immix Biopharma, Inc. (IMMX) Historical ROE (quarterly & annually)

How has IMMX ROE performed in the past?

The mean historical ROE of Immix Biopharma, Inc. over the last ten years is -48.23%. The current -102.10% ROE has changed 111.68% with respect to the historical average. Over the past ten years (40 quarters), IMMX's ROE was at its highest in in the March 2021 quarter at 21.49%. The ROE was at its lowest in in the December 2021 quarter at -126.49%.

Immix Biopharma, Inc. (IMMX) ROE by Quarter and Year

Discovering the peaks and valleys of Immix Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Immix Biopharma, Inc. (IMMX) Average ROE

How has IMMX ROE performed in the past?

The current ROE of Immix Biopharma, Inc. (IMMX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Immix Biopharma, Inc. (IMMX) ROE vs. Peers

How is IMMX’s ROE compared to its peers?

Immix Biopharma, Inc.’s ROE is greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Hepion Pharmaceuticals, Inc. (-505.74%), less than AVROBIO, Inc. (29.68%), less than eFFECTOR Therapeutics, Inc. (2.18%), less than CNS Pharmaceuticals, Inc. (695.91%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), less than Freeline Therapeutics Holdings plc (0%), greater than Enveric Biosciences, Inc. (-77.99%), greater than CohBar, Inc. (-201.01%), greater than Elevation Oncology, Inc. (-58.44%), greater than Ocean Biomedical, Inc. (-59.73%), less than null (64.85%),

Build a custom stock screener for Immix Biopharma, Inc. (IMMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immix Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immix Biopharma, Inc. (IMMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immix Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.